1. Home
  2. TRS vs FTRE Comparison

TRS vs FTRE Comparison

Compare TRS & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriMas Corporation

TRS

TriMas Corporation

HOLD

Current Price

$37.26

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.63

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRS
FTRE
Founded
1986
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
TRS
FTRE
Price
$37.26
$9.63
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$41.50
$15.39
AVG Volume (30 Days)
413.8K
2.0M
Earning Date
06-01-2026
05-25-2026
Dividend Yield
0.41%
N/A
EPS Growth
400.00
N/A
EPS
2.95
N/A
Revenue
$645,720,000.00
$2,723,400,000.00
Revenue This Year
$2.91
N/A
Revenue Next Year
$5.33
$2.96
P/E Ratio
$13.12
N/A
Revenue Growth
N/A
1.00
52 Week Low
$19.45
$3.97
52 Week High
$42.00
$18.67

Technical Indicators

Market Signals
Indicator
TRS
FTRE
Relative Strength Index (RSI) 53.33 28.61
Support Level $33.62 $9.29
Resistance Level $40.88 $11.41
Average True Range (ATR) 1.77 0.91
MACD 0.07 0.06
Stochastic Oscillator 29.37 25.39

Price Performance

Historical Comparison
TRS
FTRE

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: